John Neis - Net Worth and Insider Trading

John Neis Net Worth

The estimated net worth of John Neis is at least $20,818 dollars as of 2024-04-16. John Neis is the Director of Cellectar Biosciences Inc and owns about 6,261 shares of Cellectar Biosciences Inc (CLRB) stock worth over $20,818. Details can be seen in John Neis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Neis has not made any transactions after 2017-11-14 and currently still holds the listed stock(s).

Transaction Summary of John Neis

To

John Neis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Neis owns 2 companies in total, including Cellectar Biosciences Inc () , and Akebia Therapeutics Inc () .

Click here to see the complete history of John Neis’s form 4 insider trades.

Insider Ownership Summary of John Neis

Ticker Comapny Transaction Date Type of Owner
Cellectar Biosciences Inc 2020-06-24 director
Akebia Therapeutics Inc 2014-03-19 10 percent owner

John Neis Latest Holdings Summary

John Neis currently owns a total of 1 stock. John Neis owns 6,261 shares of Cellectar Biosciences Inc (CLRB) as of November 14, 2017, with a value of $20,818.

Latest Holdings of John Neis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CLRB Cellectar Biosciences Inc 2017-11-14 6,261 3.33 20,818

Holding Weightings of John Neis


John Neis Form 4 Trading Tracker

According to the SEC Form 4 filings, John Neis has made a total of 0 transactions in Cellectar Biosciences Inc (CLRB) over the past 5 years. The most-recent trade in Cellectar Biosciences Inc is the sale of 52 shares on November 14, 2017, which brought John Neis around $7,769.

Insider Trading History of John Neis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Neis Trading Performance

GuruFocus tracks the stock performance after each of John Neis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Neis is 35.27%. GuruFocus also compares John Neis's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Neis within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John Neis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John Neis

Average Relative Return

-3.38%

Average relative return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 24.47 35.27 4.53 -3.38 -44.49 -50.99
Relative Return to S&P 500(%) 24.65 29.25 -1.19 -18.96 -56.56 -62.95

John Neis Ownership Network

Ownership Network List of John Neis

No Data

Ownership Network Relation of John Neis


John Neis Owned Company Details

What does Cellectar Biosciences Inc do?

Who are the key executives at Cellectar Biosciences Inc?

John Neis is the director of Cellectar Biosciences Inc. Other key executives at Cellectar Biosciences Inc include Senior Vice President & Medical Andrei Shustov , Chief Commercial Officer Darrell Shane Lea , and Chief Financial Officer Chad J Kolean .

Cellectar Biosciences Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cellectar Biosciences Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellectar Biosciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cellectar Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cellectar Biosciences Inc Insider Transactions

No Available Data

John Neis Mailing Address

Above is the net worth, insider trading, and ownership report for John Neis. You might contact John Neis via mailing address: 505 S. Rosa Road, Suite 201, Madison Wi 53719.

Discussions on John Neis

No discussions yet.